Ropinirole use while Breastfeeding
Drugs containing Ropinirole: Requip, Requip XL, Repreve, ReQuip Follow on Pack, ReQuip Starter Pack, Requip Starter Kit
Ropinirole Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of ropinirole during breastfeeding, but it suppresses serum prolactin and may interfere with breastfeeding. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Possible Effects on Lactation
Relevant published information in nursing mothers was not found as of the revision date. Ropinirole lowers serum prolactin. The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
1. Acton G, Broom C. A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine d2-receptor agonist. Br J Clin Pharmacol. 1989;28:435-41. PMID: 2574051
CAS Registry Number
- Antiparkinson Agents
- Dopamine Agonists
LactMed Record Number
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Ropinirole use during Pregnancy
- Ropinirole Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy